New statement of OECD GLP compliance

Happy and proud to share that Lablytica has just received their new statement of OECD GLP compliance for Analytical and Clinical Chemistry testing (8) from SWEDACs inspection on the 10 November 2020.

Statement-of-GLP-compliance-Lablytica-Life-Science_10November-2020Ladda ner

You Might Also Like

David Pekar, CEO at Lablytica

David Pekar becomes CEO at Lablytica

november 1, 2020

Recipharm divests bioanalysis business to Center for Translational Research AB further strengthening existing partnership with CTC Clinical Trial Consultants AB

november 1, 2019
Karin Meyer, ny VD för CTR

Karin Meyer blir ny VD för Center for Translational Research Sweden AB (CTR)

januari 11, 2021